急性肾损伤至慢性肾脏病的连续体:机制与治疗干预
本文综述了急性肾损伤(AKI)向慢性肾脏病(CKD)进展的连续体机制,提出该过程经历四个机制不同的阶段:超急性损伤期(0-24小时)、急性反应-持续性AKI期(1-7天)、急性肾脏病(AKD)期(2-8周)和CKD期(>12周)。三个普遍过程整合各阶段:表观遗传损伤记忆、代谢重编程与表观遗传交叉对话、肾功能储备。主张采用基于时间信息的多阶段策略,在最佳时间窗靶向这些普遍机制,以预防或减轻不可逆的AKI-CKD连续体。
要点
- AKI影响10-15%住院患者,近四分之一进展为CKD。
- AKI-CKD连续体分为四个机制不同的阶段,各阶段有独特分子特征。
- 表观遗传记忆、代谢重编程和肾功能储备是整合各阶段的普遍过程。
核心结论
- AKI至CKD的连续体通过四个机制不同的阶段展开,需采用时间信息指导的多阶段策略靶向普遍机制。
研究设计与样本
- 本篇为综述,综合新兴证据,未报告检索范围与样本量。
主要发现
- 超急性损伤期(0-24小时)以生物能量崩溃、线粒体通透性转换、氧化应激和早期炎症启动为特征。
- 急性反应-持续性AKI期(1-7天)以PANoptosis、铁死亡、线粒体自噬受损、G2/M阻滞和细胞因子释放为特征。
- AKD期(2-8周)以适应不良修复机制为特征,包括持续TGF-β/SMAD信号、代谢重编程、YAP/TAZ激活、内皮稀疏和促纤维化非编码RNA网络稳定。
- CKD期(>12周)以不可逆细胞外基质沉积、慢性缺氧、免疫失调和肌成纤维细胞表型维持纤维化为特征。
- 三个普遍过程整合各阶段:表观遗传损伤记忆、代谢重编程与表观遗传交叉对话、肾功能储备。
关键数值与推荐
- AKI影响10-15%的住院患者,近四分之一进展为CKD。
临床怎么用
- 针对AKI-CKD连续体,应依据时间阶段在最佳时间窗靶向普遍机制,而非采用阶段不可知的单靶点方法。
局限性
- 底物可用性和细胞背景随时间变化,阶段不可知的单靶点方法无效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute kidney injury (AKI) affects 10-15% of hospitalized patients, and nearly one-quarter progress to chronic kidney disease (CKD), reflecting a failure to recognize the temporally dynamic continuum linking these conditions. This review synthesizes emerging evidence demonstrating that AKI-to-CKD continuum unfolds through four mechanistically distinct phases: (1) hyperacute injury (0-24 h), defined by bioenergetic collapse, mitochondrial permeability transition, oxidative stress, and early inflammatory priming; (2) acute response - persistent AKI (1-7 days), dominated by coordinated pyroptotic-apoptotic-necroptotic cell death (PANoptosis) and lipid peroxidation-driven ferroptosis, impaired mitophagy, aberrant G2/M arrest, and amplified cytokine release; (3) acute kidney disease (AKD) (2-8 weeks) characterized by maladaptive repair mechanisms, encompassing persistent TGF-β/SMAD signaling, metabolic reprogramming toward glycolysis, mechanotransductive YAP/TAZ activation, endothelial rarefaction, and stabilization of pro-fibrotic non-coding RNA networks; and (4) CKD (>12 weeks), where irreversible extracellular matrix deposition, chronic hypoxia, immune dysregulation, and established myofibroblast phenotypes perpetuate fibrosis. Three universal processes integrate these stages: (1) epigenetic injury memory through chromatin remodeling at pro-fibrotic loci, (2) metabolic reprogramming and epigenetic crosstalk, involving substrates such as S-adenosylmethionine and α-ketoglutarate, reinforcing self-perpetuating renal fibrosis and (3) renal functional reserve. However, substrate availability and cellular contexts are temporally variable, rendering phase-agnostic, single-target approaches ineffective because they fail to align with the evolving molecular environments. A temporally informed, multi-phase strategy that targets these universal mechanisms at optimal time-windows is crucial for preventing or attenuating this irreversible AKI-to-CKD continuum.
引用
- Kulkarni HV, Mulay SR, Gaikwad AB, et al. The AKI-CKD Continuum: Mechanisms and Therapeutic Interventions. Nephrol Dial Transplant. 2026. PMID: 42570231. doi:10.1093/ndt/gfag180
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。